Wasserman Scott M. bought IKT
October 19, 2026 · Form 4 insider transaction
Wasserman Scott M. bought 310,000 shares of Inhibikase Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
310,000
Price
$0.00
Total value
N/A
InsiderWasserman Scott M.
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 19, 2026
Filing dateOctober 21, 2026
Shares owned after310,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options will vest and become exercisable in equal annual installments over three years commencing from October 19, 2026, subject to the Reporting Person's continued service through each such vesting date.